SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-517504
Filing Date
2016-03-25
Accepted
2016-03-25 06:05:39
Documents
2
Period of Report
2016-05-09
Effectiveness Date
2016-03-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A d162694ddef14a.htm DEF 14A 305311
2 GRAPHIC g162694g0322103409379.jpg GRAPHIC 1974
  Complete submission text file 0001193125-16-517504.txt   309373
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36327 | Film No.: 161528760
SIC: 2834 Pharmaceutical Preparations